Barraquer Eye Hospital – A Global Reference in Advanced Ophthalmology in the Heart of Dubai - Middle East Business News and Information
The hospital is guided by a clear philosophy centered on deep specialization, diagnostic precision, and transparent care delivery. This approach provides patients with effective, safe, and personalized solutions for their visual problems, no matter how complex. Its commitment also extends to supporting scientific research and medical education, ensuring the hospital remains at the forefront of the rapidly evolving field of ophthalmology.
Dr. Mohsen Semaan, Medical Director at Barraquer Eye Hospital, explains:
'We don't just treat eyes — we restore vision, confidence, and quality of life. Every patient is a priority, and every procedure is carried out with utmost precision, safety, and a focus on sustainable results.'
Comprehensive Medical Services in a Specialized Environment
Barraquer Eye Hospital in Dubai offers a full range of ophthalmology and eye surgery services for all age groups and conditions, from early diagnosis to complex surgical interventions. Services include:
Vision correction surgeries (LASIK, Femto-SMILE, PRK)
Cataract treatment using the latest smart lens technologies
Retina and vitreous surgery using precision microsurgical equipment
Corneal disease treatment and corneal transplantation
Strabismus surgery and pediatric eye corrections
Glaucoma (intraocular pressure) treatment
Specialized clinics for genetic eye disorders and age-related macular degeneration
Early diagnosis of eye diseases related to diabetes and hypertension
Cutting-Edge Technology for Better Vision
Barraquer is one of the first centers in the region to integrate AI-powered diagnostic and surgical devices, enhancing both diagnostic accuracy and treatment outcomes. The hospital also utilizes optical coherence tomography (OCT), retinal imaging, and advanced 3D visual simulation systems during surgeries.
Pioneering Pediatric Ophthalmology
The hospital houses a dedicated pediatric ophthalmology department led by specialists with vast experience in handling delicate cases in infants and children. The department addresses conditions such as strabismus, amblyopia (lazy eye), blocked tear ducts, and inherited retinal disorders in newborns.
A Patient-Centered Experience with Complete Privacy
Barraquer offers an exceptional medical journey from reception to recovery within a sophisticated setting that blends European standards with Emirati hospitality—ensuring both patients and their families feel reassured and comfortable. The medical team provides detailed and personalized consultations, focusing on patient education and empowerment for informed treatment decisions.
International Academic and Scientific Partnerships
Barraquer Dubai takes pride in its strong collaboration with the original Barraquer Institute in Barcelona, offering a unique advantage in knowledge transfer and continuous training for its medical team. The hospital also participates in advanced international research, especially in rare or genetic eye diseases, helping enhance treatment effectiveness.
Location & Contact
Barraquer Eye Hospital is strategically located in the Al Jaddaf area of Dubai. Appointments can be booked easily through the website or via direct contact with the hospital's dedicated admin team.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
See - Sada Elbalad
03-08-2025
- See - Sada Elbalad
Sweden Leads Europe in Smoke-Free Innovation
Israa Farhan During a recent visit to Sweden, Sada El Balad met with several experts and industry professionals specializing in the development of smoke-free products and better alternatives to traditional cigarettes. The delegation toured multiple production sites and scientific facilities committed to research and innovation in less harmful nicotine alternatives and smoke-free alternatives to traditional cigarettes. One of the main stops was at the labs of Swedish Match—now a subsidiary of Philip Morris International (PMI)—which produces snus and nicotine pouches such as ZYN. Experts explained the rigorous quality assurance processes used to test these products, including their exposure to varying levels of heat, humidity, and pressure to simulate different global climates. This ensures the consistency and reliability of the product's nicotine delivery while maintaining its quality across international markets. Among those interviewed was Samuel Lundell, Chairman of the National Association of Snus Users in Sweden. He explained that snus and nicotine pouches offer adult smokers a less harmful alternative to smoking. These products still deliver nicotine but in a different form and with reduced risk. He pointed out that the design of nicotine pouches has evolved over time, with smaller, more discreet sizes that appeal especially to women, many of whom previously preferred the aesthetics of traditional smoking. The latest flavors and pouch designs aim to support female smokers in their journey to switch to less harmful alternatives, offering both ease of use and better health outcomes. Lundell added that the main mission of the association is to protect the rights of snus and nicotine pouch users. 'The association is fully independent,' he said, 'funded exclusively by its members. We do not accept financial support from tobacco companies or government institutions to preserve our freedom of speech and defend consumer rights effectively.' In another discussion, Dr. Anders Milton, former CEO and President of the Swedish Medical Association, emphasized that the number of smoking-related cancers is declining in Sweden among consumers of alternative smoking products, particularly nicotine pouches and snus. Several studies have found that the incidence of cancers in the human organs involved in alternative smoking (mouth, esophagus, lungs, and stomach) in Sweden is lower than in all other European countries, especially since there has been concern about the direct absorption of nicotine from these products through the mouth, passing through the throat and reaching the stomach. Milton continued, "We have not found any negative impact in the form of increased cancer rates among smokers of less harmful alternative products. Although smoking rates are generally low, the incidence of cancer remains lower than in all European countries, and lower than the average rates in the European Union." The visit concluded with a meeting with Patrik Hildingsson, Director Oral Category Communications at Philip Morris International. Hildingsson revealed that PMI has invested nearly $14 billion in scientific research since 2008 to develop and validate smoke-free, less harmful alternatives to traditional tobacco products. He noted that several of PMI's smoke-free products have received regulatory authorizations from health authorities in various countries, including the U.S. Food and Drug Administration (FDA). He added that Swedish Match was acquired by Philip Morris International about two years ago, and is distinguished by its alternative products of snus and nicotine pouches. It operates three facilities in Sweden dedicated to the production and development of nicotine pouches and snus, including three manufacturing sites and three flagship stores serving a diverse customer base. These stores also support product customization and flavor innovation to better suit consumer preferences. 'Sweden has one of the lowest smoking rates in Europe,' Hildingsson concluded, 'and a large percentage of nicotine users have transitioned to smoke-free alternatives. This has had a tangible impact on public health, as Sweden now reports the lowest incidence of smoking-related diseases across the continent. read more Gold prices rise, 21 Karat at EGP 3685 NATO's Role in Israeli-Palestinian Conflict US Expresses 'Strong Opposition' to New Turkish Military Operation in Syria Shoukry Meets Director-General of FAO Lavrov: confrontation bet. nuclear powers must be avoided News Iran Summons French Ambassador over Foreign Minister Remarks News Aboul Gheit Condemns Israeli Escalation in West Bank News Greek PM: Athens Plays Key Role in Improving Energy Security in Region News One Person Injured in Explosion at Ukrainian Embassy in Madrid News Israeli-Linked Hadassah Clinic in Moscow Treats Wounded Iranian IRGC Fighters Arts & Culture "Jurassic World Rebirth" Gets Streaming Date News China Launches Largest Ever Aircraft Carrier News Ayat Khaddoura's Final Video Captures Bombardment of Beit Lahia Business Egyptian Pound Undervalued by 30%, Says Goldman Sachs Videos & Features Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall Lifestyle Get to Know 2025 Eid Al Adha Prayer Times in Egypt Arts & Culture South Korean Actress Kang Seo-ha Dies at 31 after Cancer Battle Arts & Culture Lebanese Media: Fayrouz Collapses after Death of Ziad Rahbani Sports Get to Know 2025 WWE Evolution Results
Al-Ahram Weekly
31-07-2025
- Al-Ahram Weekly
Building prosthetic expertise - Economy - Al-Ahram Weekly
Ahmed, in his 40s, is a garage attendant working in a middle-class neighbourhood of Cairo. He relies on crutches after the amputation of one leg. Just two streets away, a 10-year-old boy is playing football. He, too, lives with a disability, as his left hand has been amputated. Neither Ahmed nor the boy has considered using prosthetic limbs. Both belong to vulnerable segments of society and remain unaware of how to access such support through civil society organisations. According to the Central Agency for Public Mobilisation and Statistics, people with disabilities made up approximately 11 per cent of Egypt's population in 2017, with motor disabilities accounting for about 6.8 per cent. To help out this segment of the population, the government is taking steps to localise the production of prosthetic limbs and orthotic devices. The Ministry of Social Solidarity and other relevant authorities are taking the initiative in line with the political leadership's directives to advance this sector. Margaret Saroufim, deputy minister of social solidarity, told Al-Ahram Weekly that 'Egypt is currently developing a system for prosthetic limbs and orthotics, because up till now we have been heavily relying on imported components, especially for limbs with advanced technical specifications, due to the absence of a specialised local industry.' She added that some civil society organisations, including NGOs overseen by the ministry, provide limited services such as basic assembly, maintenance, and adjustments of prosthetic limbs. A national project has now been launched to establish centres for the localisation of prosthetic limb manufacturing in several governorates, Saroufim said, adding that the next step will be establishing an integrated national service system. 'The project will serve as a nucleus for delivering comprehensive services including assessment, fitting, and post-fitting support, while also focusing on technical training in partnership with international experts. This is an important step towards achieving self-sufficiency and providing services in line with international standards and sustainable quality,' she said. Haitham Al-Tabaai, executive director of the Abwab Al-Khair Foundation, a NGO, has been providing prosthetic limbs and devices to those in need for the past 12 years. 'The cost of prosthetic limbs has risen dramatically. When I first began working in the sector, the average price was LE9,000. Just two weeks ago, it was LE55,000,' he said. The price of prosthetic limbs is at the mercy of the dollar exchange rate, he said. One man whose son lost a leg in a train accident had kept saving up to buy a prosthetic limb for his son, but each time he had enough money, the price had risen again, he added. 'Eventually, he had no choice but to seek help from a civil society organisation. It was a heavy burden for him to ask for assistance.' Rising prices have meant that Egypt has abandoned the European market and sought imports from other markets such as Russia, South Africa, and China, which are of lower quality but are much more reasonably priced, Al-Tabaai added. Localising the manufacture of prosthetic limbs and orthotics in Egypt will be a positive step if high-quality products can be provided at a reasonable cost, he added, noting that more NGOs would then be able to offer support in this domain. Saroufim said that one of the key challenges of localising this industry os the absence of the specialised industrial infrastructure capable of producing prosthetic components in accordance with international standards. There is a lack of technological and technical capabilities in this field as well as a shortage of qualified workers, she said, adding that the lack of an integrated system that encompasses training, operations, distribution, and quality control contributes to the problem. Up to now, Egypt has completely depended on imported raw materials and essential components in this field. To address these challenges, Egypt has formed a technical committee made up of representatives from over 30 ministries, authorities, and relevant institutions tasked with studying and overcoming problems hindering the localisation of prosthetic limbs manufacturing on the national level, Saroufim said. The Ministry of Social Solidarity has been tasked with establishing 42 prosthetic limb assembly and fitting centres, to be implemented in six phases. The first phase, already underway, includes the launch of six centres in the Sharqia, Beheira, Ismailia, Assiut, Luxor, and Aswan governorates, she said. 'A leading German company, Ottobock, has been contracted to supply the equipment needed in the centres, provide technical support, and train Egyptian staff to operate the systems,' she added. Establishing a specialised centre for the production and assembly of prosthetic limbs requires a range of technical, structural, and administrative prerequisites, including appropriate infrastructure, modifications to internal engineering systems, and the division of workspaces to align with the various technical stages involved in prosthetic manufacturing, she explained. 'The centres must also be situated near Ministry of Health hospitals to ensure the availability of integrated medical services. Equally important is the design of physically accessible facilities to ensure ease of use for persons with disabilities.' 'Factories producing prosthetic limbs and devices are already active, but they lack new technologies, product quality, and skilled human resources,' Saroufim noted. She referred to the wide variation in the cost of prosthetic limbs, which depends on the type, level of complexity, whether fixed or mobile, and factors such as age appropriateness and the user's daily activity requirements. 'Imported prosthetic limbs are among the most expensive due to their reliance on precision components and specialised technologies,' she added. In distributing prosthetic limb manufactured by national centres, the most vulnerable groups will also be prioritised, Saroufim stated. The disbursement mechanism is structured into three categories: full state coverage for families classified under priority care; partial financial contribution based on socioeconomic assessment; and responsibility to cover the full costs for people who do not meet the eligibility requirements for support. Eligibility will be determined through a medical evaluation approved by the Ministry of Health or its affiliated institutions, which defines the individual's health status and specifies the type of prosthetic limb required. An evaluation conducted by the Ministry of Social Solidarity will also assess the beneficiary's economic and social conditions, determining whether they qualify for full, partial, or no financial support, she said. 'This system upholds social justice while preserving the dignity of citizens by ensuring access to prosthetic limbs that are appropriate to their medical and personal circumstances,' she stressed. The Ministry of Social Solidarity is currently developing a database to identify people with mobility impairments who require prosthetic limbs or devices using information from the Medical Commission and the Integrated Services System that classifies cases according to the type and severity of disability, as well as the actual level of need, Saroufim added. According to data released in July, there are 1.2 million people with mobility disabilities in Egypt, she said, calling on people with impairments to register in the Integrated Services System to determine their needs. * A version of this article appears in print in the 6 August, 2025 edition of Al-Ahram Weekly Follow us on: Facebook Instagram Whatsapp Short link:
Daily News Egypt
28-07-2025
- Daily News Egypt
Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion
Triquera B.V., the majority shareholder of Egyptian biopharmaceutical leader Minapharm, has secured a minority investment from Admaius Capital Partners in a landmark deal aimed at accelerating the regional and global expansion of Minapharm's biotechnology footprint. Admaius, an Africa-focused private equity firm, joins forces with Triquera to support the continued growth of Minapharm, which operates one of the largest biological drug substance and product facilities in the Middle East and Africa. The company is renowned for its end-to-end capabilities in manufacturing complex recombinant proteins, viral vectors, and advanced biologics, with operations in both Cairo and Berlin. The strategic partnership is expected to fast-track the development and distribution of affordable, high-quality genetically engineered therapies across underserved markets in Africa and the Middle East. It will also focus on expanding Minapharm's licensing of proprietary technologies in monoclonal antibodies, cell and gene therapies, and vaccines—many of which have been incorporated into FDA-approved products. The collaboration includes plans to explore strategic acquisitions of global contract development and manufacturing organizations (CDMOs), further positioning Minapharm as a competitive force in the global biotech industry. Strategic Alignment and Regional Impact Dr. Wafik Bardissi, Chairman and CEO of Minapharm, welcomed the partnership, stating: 'With Admaius, we gain not only capital but a strategic partner whose insight, alignment, and ambition match our own. Together, we are advancing regional self-sufficiency and expanding the global reach of our innovations.' Admaius Capital Partners Managing Partner Marlon Chigwende described the deal as a 'landmark transaction,' adding: 'The founding families have built a unique asset on the African and European continents that combines scale, growth, and impact to fight cancer and other awful diseases.' Ahmed Rady, Managing Director at Admaius, praised the Minapharm team's scientific and operational capabilities: 'This partnership is about scaling a homegrown champion that combines cutting-edge global know-how with end-to-end manufacturing excellence.' Dr. Shaheer Bardissi, Co-CEO of Minapharm, emphasized the broader industry implications of the deal: 'This strategic collaboration with Admaius will accelerate and scale Minapharm's vision of translating cutting-edge scientific innovation into affordable therapies, while advancing global scientific frontiers in immunotherapy and advanced therapy medicinal products.' Advisory Teams Zilla Capital acted as the sole financial advisor to Triquera and existing shareholders, while legal counsel was provided by Matouk Bassiouny. Admaius Capital Partners was advised by White & Case LLP and commercial consultant Arthur D. Little.
